HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bullous erythema nodosum leprosum manifesting in the post partum period with unusual features.

Abstract
A 30 year old woman who presented with multiple numb patches on the body was initially diagnosed as borderline lepromatous leprosy and started on multidrug therapy for leprosy. She had an episode of Type 1 reaction during the fifth month of pregnancy. After delivery, she stopped therapy fearing harm to her child and developed an episode of Type 2 reaction. The reaction was unusual in that bullous lesions developed over previous leprosy patches which had initially become indurated, with associated neuritis. Histopathology revealed bullae with intense neutrophilic reaction and strong positivity for acid fast bacilli. There was no response to steroid therapy which was started for the reaction. Thalidomide had to be prescribed after stopping lactation by medical means. She responded dramatically to Thalidomide with regression of cutaneous lesions and neuritis. This patient is being reported as a very unusual manifestation of bullous erythema nodosum leprosum in the postpartum period responding dramatically to thalidomide.
AuthorsRajesh Verma, Biju Vasudevan, Vijendran Pragasam, Nikhil Moorchung, Debdeep Mitra, Manoj Gopal
JournalLeprosy review (Lepr Rev) Vol. 86 Issue 1 Pg. 96-101 (Mar 2015) ISSN: 0305-7518 [Print] England
PMID26065152 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Leprostatic Agents
  • Thalidomide
Topics
  • Adult
  • Erythema Nodosum (diagnosis, drug therapy)
  • Female
  • Humans
  • Leprostatic Agents (therapeutic use)
  • Leprosy, Borderline (diagnosis, drug therapy)
  • Leprosy, Lepromatous (diagnosis, drug therapy)
  • Postpartum Period
  • Pregnancy
  • Pregnancy Complications (diagnosis, drug therapy)
  • Thalidomide (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: